Display options
Share it on

United European Gastroenterol J. 2018 Oct;6(8):1188-1198. doi: 10.1177/2050640618786067. Epub 2018 Jun 27.

Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals.

United European gastroenterology journal

Veronika Pietsch, Katja Deterding, Dina Attia, Kristina Imeen Ringe, Benjamin Heidrich, Markus Cornberg, Michael Gebel, Michael Peter Manns, Heiner Wedemeyer, Andrej Potthoff

Affiliations

  1. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  2. Department of Gastroenterology and Hepatology, University of Essen, Essen, Germany.
  3. Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.

PMID: 30288281 PMCID: PMC6169054 DOI: 10.1177/2050640618786067

Abstract

BACKGROUND: The use of interferon-free direct-acting antiviral agents (DAAs) is associated with a rapid short-term decrease in liver stiffness in chronic hepatitis C-infected patients with sustained virologic response (SVR).

OBJECTIVE: The objective of this article is to evaluate long-term changes in liver elasticity in hepatitis C patients with SVR using transient elastography (TE), FIB-4 and APRI.

METHODS: A total of 143 patients were treated with DAAs and reached SVR. Patients received TE measurement (median (range)) at treatment start (baseline), follow-up week 24 (FU24) and follow-up week 96 (FU96). Laboratory data were examined at each date and FIB-4 and APRI were calculated.

RESULTS: Liver elasticity showed a significant decrease from baseline to FU24 (13.1 (3.1-75) kPa to 9.3 (2.9-69.1) kPa;

CONCLUSION: During long-term follow-up, the majority of patients with SVR had further improved liver stiffness values. Still, a significant proportion of patients may show long-term liver stiffness progression and thus continued TE follow-up is recommended.

Keywords: DAAs; HCV infection; Hepatitis C; SVR; direct-acting antivirals; liver elastography; liver stiffness; portal hypertension; sustained virological response; transient elastography

References

  1. N Engl J Med. 2014 Apr 17;370(16):1483-93 - PubMed
  2. J Gastroenterol Hepatol. 2016 Jun;31(6):1168-76 - PubMed
  3. J Hepatol. 2016 Jun;64(6):1224-31 - PubMed
  4. PLoS One. 2017 Oct 24;12(10):e0185609 - PubMed
  5. J Hepatol. 2013 Aug;59(2):251-6 - PubMed
  6. J Hepatol. 2010 Jul;53(1):36-42 - PubMed
  7. N Engl J Med. 2014 Jan 16;370(3):211-21 - PubMed
  8. J Gastroenterol Hepatol. 2017 Sep;32(9):1624-1630 - PubMed
  9. J Gastroenterol Hepatol. 2010 May;25(5):964-9 - PubMed
  10. Z Gastroenterol. 2017 Sep;55(9):848-856 - PubMed
  11. Gastroenterology. 2016 Sep;151(3):457-471.e5 - PubMed
  12. Ultrasound Med Biol. 2003 Dec;29(12):1705-13 - PubMed
  13. Hepatology. 2006 Jun;43(6):1317-25 - PubMed
  14. N Engl J Med. 2014 May 15;370(20):1889-98 - PubMed
  15. PLoS One. 2016 Jul 21;11(7):e0159413 - PubMed
  16. Hepatology. 2003 Aug;38(2):518-26 - PubMed
  17. Aliment Pharmacol Ther. 2017 Jan;45(1):139-149 - PubMed
  18. Liver Int. 2017 Mar;37(3):369-376 - PubMed
  19. Aliment Pharmacol Ther. 2015 Oct;42(7):889-901 - PubMed
  20. J Viral Hepat. 2016 Dec;23(12):994-1002 - PubMed
  21. Dig Dis Sci. 2018 Feb;63(2):486-492 - PubMed
  22. J Viral Hepat. 2017 Oct;24(10):823-831 - PubMed
  23. J Hepatol. 2008 May;48(5):835-47 - PubMed
  24. Gastroenterology. 2016 Feb;150(2):419-29 - PubMed
  25. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):401-12 - PubMed
  26. Lancet. 1997 Mar 22;349(9055):825-32 - PubMed
  27. J Viral Hepat. 2013 Jan;20(1):72-6 - PubMed
  28. Gastroenterology. 2008 Apr;134(4):960-74 - PubMed
  29. Aliment Pharmacol Ther. 2011 Sep;34(6):656-63 - PubMed
  30. Hepatology. 1994 Jul;20(1 Pt 1):15-20 - PubMed
  31. Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62 - PubMed
  32. Ultraschall Med. 2017 Aug;38(4):e16-e47 - PubMed
  33. J Hepatol. 2015 Jul;63(1):237-64 - PubMed
  34. Hepatology. 2011 Mar;53(3):726-36 - PubMed

Publication Types